Oncology
Commentary
CRC: Troubling Mortality Rates for a Preventable Cancer
The rates of 6 of the top 10 cancers have been increasing over the past several years.
Feature
Is Mammography Ready for AI? Opinions Mixed on Usage, Cost Methods
Patients can pay to get their mammograms read by AI.
Latest News
This Could Be a Strong Weapon for Cancer Pain (or Any Pain)
Patients with cancer who experience pain can find relief with exercise for more than 30 minutes on most days, study finds.
From the Journals
Is MRI Screening Unnecessarily High in Prostate Cancer?
Expert emphasizes the necessity of observing a decrease in overall prostate cancer incidence before asserting that the current cancer diagnostics...
Latest News
FDA Approves First Cellular Therapy for Metastatic Melanoma
Patients with metastatic melanoma have potential new treatment option with approval of T-cell immunotherapy.
Latest News
Should CRC Surveillance Extend Beyond 5 Years Post Surgery?
“Symptoms or suspicion of a cancer occurring 5-10 years from primary CRC treatment is more likely to represent a non-CRC cancer.”
Latest News
Hyperbaric Oxygen: Effective Against Cancer Radiation Harm?
New study on hyperbaric oxygen therapy does not clarify benefit for patients following radiation.
Latest News
Despite Good Prognosis, Early Melanoma Sparks Fear of Recurrence
In a small study, patients successfully treated for early, localized cutaneous melanoma expressed anxieties about recurrence, life changes, and...
Latest News
New Trials in Gynecologic Cancers: Could Your Patient Benefit?
Several trials are enrolling for patients with gynecologic cancers, which could be appropriate for a range of patients.
Latest News
Cancer Surgery Tied to Increased Venous Thromboembolism Risk
The temporal trends showed that the risk for pulmonary embolism and deep vein thrombosis peaked immediately after surgery and plateaued within 120...
Latest News
Plant-Based Diet a Boon for Men With Prostate Cancer
A diet of fresh vegetables and fruit with few animal-based products is linked to reduced risk for recurrent prostate cancer, says study.